Feeney John Joseph 4

4 · Vanda Pharmaceuticals Inc. · Filed Feb 21, 2012

Form 4

Period: 2012-02-16

Acting Chief Medical Officer

Transactions

Exercise/Conversion
Common Stock
2012-02-16+7,500→ 15,000 total
Exercise/Conversion
Common Stock
2012-02-16+4,687→ 19,687 total
Sale
Common Stock
2012-02-16$4.65/sh−4,760$22,152→ 14,927 total
Exercise/Conversion
Restricted Stock Unit
2012-02-16−7,500→ 15,000 total
→ Common Stock (7,500 underlying)
Exercise/Conversion
Restricted Stock Unit
2012-02-16−4,687→ 14,063 total
→ Common Stock (4,687 underlying)

Footnotes (5)

[F1]Each Restricted Stock Unit represents a contingent right to receive a share of the Issuer's common stock.
[F2]This transaction was executed in multiple trades at prices ranging from $4.62 to $4.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
[F3]The Restricted Stock Units vest in four equal annual installments beginning January 1, 2011. Vested shares will be delivered on the First Permissable Trading Day (as defined in the Restricted Stock Unit Agreement) that occurs on or after the day when the Restricted Stock Units vest.
[F4]N/A
[F5]The Restricted Stock Units vest in four equal annual installments beginning January 1, 2012. Vested shares will be delivered on the First Permissable Trading Day (as defined in the Restricted Stock Unit Agreement) that occurs on or after the day when the Restricted Stock Units vest.

Documents

1 file